Literature DB >> 11673468

The Cys-67 residue of HLA-B27 influences cell surface stability, peptide specificity, and T-cell antigen presentation.

I Alvarez1, M Martí, J Vázquez, E Camafeita, S Ogueta, J A López de Castro.   

Abstract

Cys-67 of HLA-B27 is located in the B pocket, which determines peptide-binding specificity. We analyzed effects of the Cys-67 --> Ser mutation on cell surface expression, peptide specificity, and T-cell recognition of HLA-B*2705. Surface expression was assessed with antibodies recognizing either native or unfolded HLA proteins. Whereas native B*2705 molecules predominated over unfolded ones, this ratio was reversed in the mutant, suggesting lower stability. Comparison of B*2705- and Cys-67 --> Ser-bound peptides revealed that the mutant failed to bind approximately 15% of the B*2705 ligands, while binding as many novel ones. Two peptides with Gln-2 found in both B*2705 and Cys-67 --> Ser are the first demonstration of natural B*2705 ligands lacking Arg-2. Other effects of the mutation on peptide specificity were: 1) average molecular mass of natural ligands higher than for B*2705, 2) bias against small residues at peptide position (P) 1, and 3) increased P2 permissiveness. The results suggest that the Cys-67 --> Ser mutation weakens B pocket interactions, leading to decreased stability of the mutant-peptide complexes. This may be partially compensated by interactions involving bulky P1 residues. The effect of the mutation on allorecognition was consistent with that on peptide specificity. Our results may aid understanding of the pathogenetic role of HLA-B27 in spondyloarthropathy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11673468     DOI: 10.1074/jbc.M108882200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  PRBAM: a new tool to analyze the MHC class I and HLA-DR anchor motifs.

Authors:  Anna Mestre-Ferrer; Erika Scholz; Jepi Humet-Alsius; Iñaki Alvarez
Journal:  Immunology       Date:  2018-11-22       Impact factor: 7.397

2.  The Human Leukocyte Antigen (HLA)-B27 Peptidome in Vivo, in Spondyloarthritis-susceptible HLA-B27 Transgenic Rats and the Effect of Erap1 Deletion.

Authors:  Eilon Barnea; Dganit Melamed Kadosh; Yael Haimovich; Nimman Satumtira; Martha L Dorris; Mylinh T Nguyen; Robert E Hammer; Tri M Tran; Robert A Colbert; Joel D Taurog; Arie Admon
Journal:  Mol Cell Proteomics       Date:  2017-02-10       Impact factor: 5.911

3.  Characterization of a proteasome and TAP-independent presentation of intracellular epitopes by HLA-B27 molecules.

Authors:  Adriana Magnacca; Irene Persiconi; Elisa Nurzia; Silvana Caristi; Francesca Meloni; Vincenzo Barnaba; Fabiana Paladini; Domenico Raimondo; Maria Teresa Fiorillo; Rosa Sorrentino
Journal:  J Biol Chem       Date:  2012-07-17       Impact factor: 5.157

4.  Peptide handling by HLA-B27 subtypes influences their biological behavior, association with ankylosing spondylitis and susceptibility to endoplasmic reticulum aminopeptidase 1 (ERAP1).

Authors:  Noel García-Medel; Alejandro Sanz-Bravo; Carlos Alvarez-Navarro; Patricia Gómez-Molina; Eilon Barnea; Miguel Marcilla; Arie Admon; José A López de Castro
Journal:  Mol Cell Proteomics       Date:  2014-09-03       Impact factor: 5.911

5.  Two MHC class I molecules associated with elite control of immunodeficiency virus replication, Mamu-B*08 and HLA-B*2705, bind peptides with sequence similarity.

Authors:  John T Loffredo; John Sidney; Alex T Bean; Dominic R Beal; Wilfried Bardet; Angela Wahl; Oriana E Hawkins; Shari Piaskowski; Nancy A Wilson; William H Hildebrand; David I Watkins; Alessandro Sette
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.